A detailed history of Stonepine Capital Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 2,458,873 shares of ACRS stock, worth $7.11 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
2,458,873
Previous 1,927,446 27.57%
Holding current value
$7.11 Million
Previous $2.12 Billion 33.37%
% of portfolio
1.79%
Previous 1.93%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.12 - $1.4 $595,198 - $743,997
531,427 Added 27.57%
2,458,873 $2.83 Billion
Q2 2024

Aug 13, 2024

BUY
$1.01 - $1.36 $1.95 Million - $2.62 Million
1,927,446 New
1,927,446 $2.12 Billion

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $193M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.